Cullinan Therapeutics, Inc.
CGEMCIK 0001789972 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
8,011 bought / 8,000 sold
net +11 sh · −$90.9K
- buys
- 3
- sells
- 1
- insiders active
- 3
Filing tape
Filed Tue, Jul 7, 2026
- −4,000 sh · $125.4K
Michaelson Jennifer — Chief Scientific Officer
- Exercised4,000Common Stock@ $4.30→ 170,844 held
- Sold8,000Common Stock@ $17.82→ 162,844 held
- Exercised4,000Stock Option (Right to Buy)→ 112,987 held
Filed Thu, Jul 2, 2026
- +2,470 sh · $21.2K
Sumer Jacquelyn L — Chief Legal Officer
- Granted2,470Common Stock@ $8.60→ 130,559 held
- +1,541 sh · $13.3K
Fenton Mary Kay — Chief Financial Officer
- Granted1,541Common Stock@ $8.60→ 127,921 held
Insiders on this tape
- Michaelson JenniferChief Scientific Officer
- Sumer Jacquelyn LChief Legal Officer
- Fenton Mary KayChief Financial Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.